LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 205

Search options

  1. Article ; Online: Commentary:Beta-blockers and sleep problems.

    Pope, Elena

    Pediatric dermatology

    2021  Volume 38, Issue 2, Page(s) 378–379

    MeSH term(s) Adrenergic beta-Antagonists/adverse effects ; Humans ; Sleep Wake Disorders/drug therapy
    Chemical Substances Adrenergic beta-Antagonists
    Language English
    Publishing date 2021-04-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605539-4
    ISSN 1525-1470 ; 0736-8046
    ISSN (online) 1525-1470
    ISSN 0736-8046
    DOI 10.1111/pde.14537
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Dermatitis versus nonaccidental trauma: A systematic review of initial pediatric misdiagnoses.

    King, Aliyah / Pope, Elena

    Pediatric dermatology

    2024  Volume 41, Issue 2, Page(s) 215–220

    Abstract: Background/objectives: Pediatric dermatitis and nonaccidental trauma (NAT) may have overlapping cutaneous presentations, posing a risk of misdiagnosis and subsequent emotional distress and further harm. Through a systematic literature review, we ... ...

    Abstract Background/objectives: Pediatric dermatitis and nonaccidental trauma (NAT) may have overlapping cutaneous presentations, posing a risk of misdiagnosis and subsequent emotional distress and further harm. Through a systematic literature review, we reviewed pediatric (<18 years old) patients investigated for both dermatitis and NAT.
    Methods: EMBASE and MEDLINE databases were searched. English publications with original data involving pediatric patients investigated for both dermatitis and NAT were included. Nonhuman studies and incomplete articles/conference abstracts were excluded. Data extracted included the first author, year of publication, study design, participant count, sex of the population, age of the population, cutaneous presentation, timing of presentation, Child Protective Services involvement, and case relation to dermatitis and NAT.
    Results: This review included 21 case reports or series encompassing 29 patients. Among 26 patients initially investigated as NAT (26.9% involving Child Protective Services), final diagnoses included irritant contact dermatitis (53.8%), phytophotodermatitis (30.8%), allergic contact dermatitis (7.7%), perianal infectious dermatitis (3.8%), and atopic dermatitis (3.8%). Three patients initially diagnosed with nontraumatic dermatitis were later found to be victims of physical (2/3; 66.7%) or sexual abuse (1/3; 33.3%).
    Conclusions: Effective history-taking and physical examinations should encompass a history of laxative use, contact with furocoumarin-containing plants/fruit, parallel family/peer cutaneous presentations, caregiver involvement, financial burden, patient discomfort, birthmark assessment, and lesions aligning with diaper borders or toilet seats. Limitations of this review include potential underreporting and the inclusion of low-quality study designs and evidence.
    MeSH term(s) Child ; Humans ; Adolescent ; Child Abuse/diagnosis ; Laxatives ; Dermatitis, Phototoxic ; Dermatitis, Atopic ; Diagnostic Errors
    Chemical Substances Laxatives
    Language English
    Publishing date 2024-02-24
    Publishing country United States
    Document type Systematic Review ; Journal Article
    ZDB-ID 605539-4
    ISSN 1525-1470 ; 0736-8046
    ISSN (online) 1525-1470
    ISSN 0736-8046
    DOI 10.1111/pde.15556
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Oral ivermectin treatment for an infant with crusted scabies.

    Bourkas, Adrienn N / Pope, Elena

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

    2023  Volume 195, Issue 9, Page(s) E334

    MeSH term(s) Infant ; Humans ; Ivermectin/therapeutic use ; Scabies/diagnosis ; Scabies/drug therapy
    Chemical Substances Ivermectin (70288-86-7)
    Language English
    Publishing date 2023-03-05
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 215506-0
    ISSN 1488-2329 ; 0008-4409 ; 0820-3946
    ISSN (online) 1488-2329
    ISSN 0008-4409 ; 0820-3946
    DOI 10.1503/cmaj.221385
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: iscorEB-p: A patient-reported outcome measure for Epidermolysis bullosa. Psychometric properties of the Patient Score from the Instrument for Scoring Clinical Outcome of Research for EB.

    Salamon, Gudrun / Strobl, Sophie / Field-Werners, Ursula / Diem, Anja / Schwieger-Briel, Agnes / Pope, Elena

    The British journal of dermatology

    2024  

    Abstract: Background: In contrast to clinical diagnosis via external examination, patient-related outcome measures allow to access the patients' internal perception. Particularly, in the case of epidermolysis bullosa (EB), a rare disease characterized by a wide ... ...

    Abstract Background: In contrast to clinical diagnosis via external examination, patient-related outcome measures allow to access the patients' internal perception. Particularly, in the case of epidermolysis bullosa (EB), a rare disease characterized by a wide variety of symptoms and individual courses of disease, it is central to integrate the patient's perspective into diagnostic processes.
    Objectives: The Instrument for Scoring Clinical Outcome of Research for EB (iscorEB) is an EB-specific measurement tool, combining a clinician score (iscorEB-c) and a patient questionnaire (iscorEB-p). The aim of this study is to establish the iscorEB-p as an independent patient-related outcome measure tool by exploring its psychometric properties.
    Methods: The following steps were performed on data collected via a multinational online cross-sectional study: sample-based psychometric testing and evaluation.
    Results: Data analysis was performed with n=95 participants across all EB types. The reliability and internal consistency of the iscorEB-p was excellent (α=0.90). A principal component analysis with a varimax rotation resulted in a two-factor solution, explaining 55.6% of the total variance, with the distinct factors "everyday life functioning" and "specific EB symptoms". Convergent validity was shown by high correlations to the SWLS (r=-0.52, p<0.001), the QOLEB (r=0.72, p<0.001) and EB-BoD (r=-0.73, p<0.001).
    Conclusions: In conclusion, the iscorEB-p is a reliable and valid instrument to assess the patient-reported view on the health status of EB patients.
    Language English
    Publishing date 2024-01-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1093/bjd/ljae019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Evaluation of Methotrexate Intolerance in Children With Morphea.

    McColl, Jeanine / Laxer, Ronald M / Pope, Elena / Sibbald, Cathryn

    The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

    2023  Volume 28, Issue 6, Page(s) 559–564

    Abstract: Objective: Methotrexate is an immunosuppressant commonly used in dermatology. The prevalence of intolerance using the Methotrexate Intolerance Severity Score (MISS) in pediatric juvenile idiopathic arthritis (JIA) ranges from 25% to 75%, but studies in ... ...

    Abstract Objective: Methotrexate is an immunosuppressant commonly used in dermatology. The prevalence of intolerance using the Methotrexate Intolerance Severity Score (MISS) in pediatric juvenile idiopathic arthritis (JIA) ranges from 25% to 75%, but studies in morphea patients are lacking. We sought to determine the prevalence and predictors of methotrexate intolerance in children with morphea compared with children with inflammatory skin diseases and JIA/uveitis.
    Methods: Eligible patients were ages 2 to 18 years and were taking methotrexate for at least 3 months to treat morphea, inflammatory skin disease, or uveitis/JIA. Methotrexate intolerance was calculated using the MISS. A 1-way analysis of variance compared absolute intolerance scores. Multivariate regression analysis was used to compare MISS across diseases and covariates.
    Results: Of 48 participants (mean ± SD age, 11.3 ± 4.1 years, 70.8% female), 15 had morphea, 16 had JIA/uveitis, and 17 had inflammatory skin diseases. The overall prevalence of intolerance was 20.8%. Age, sex, duration, and dose did not correlate with overall MISS. The MISS mean ± SD total for oral dosing was 2.5 ± 3.4, compared with 6.78 ± 6.8 for subcutaneous dosing. Patients with JIA/uveitis had the highest prevalence of intolerance (37.5%, n = 6), followed by morphea patients (20%, n = 3) and inflammatory skin disease patients (5.9%, n = 1). The OR of intolerance according to route of administration was 11.2 (95% CI, 2.03-61.89).
    Conclusions: Methotrexate intolerance was highest among patients with JIA/uveitis. The only predictor for risk of intolerance was subcutaneous route of administration. Future work could examine disease activity correlations and interventions designed to minimize intolerance.
    Language English
    Publishing date 2023-10-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3028543-4
    ISSN 1551-6776
    ISSN 1551-6776
    DOI 10.5863/1551-6776-28.6.559
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Coronavirus Disease 2019-Related Oral Reactive Infectious Mucocutaneous Eruption.

    Linaksita, Brandon / Georgakopoulos, Jorge R / Pope, Elena / Stallaert, Karen

    Journal of dentistry for children (Chicago, Ill.)

    2023  Volume 89, Issue 3, Page(s) 199–202

    Abstract: The coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19), is well-known for its respiratory symptoms. The scientific community and frontline health care providers have been documenting a number of systemic ... ...

    Abstract The coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19), is well-known for its respiratory symptoms. The scientific community and frontline health care providers have been documenting a number of systemic manifestations, including clinical findings in the oral cavity. Among these findings, oral ulcerative lesions are becoming more prevalent in COVID-19 infection, with differing severities and presentations. Health care professionals should, therefore, be aware of the possible implications that COVID-19 has on the oral cavity to judiciously document, monitor and refer patients with ulcerative lesions to the appropriate medical and dental specialists for management when necessary.
    MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Communicable Diseases ; Pandemics ; Health Personnel
    Language English
    Publishing date 2023-05-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 390120-8
    ISSN 1935-5068 ; 1551-8949 ; 0022-0353
    ISSN (online) 1935-5068
    ISSN 1551-8949 ; 0022-0353
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The Burden of Disease in Alopecia Areata: Canadian Online Survey of Patients and Caregivers.

    Gilding, Anthony Justin / Ho, Nhung / Pope, Elena / Sibbald, Cathryn

    JMIR dermatology

    2022  Volume 5, Issue 4, Page(s) e39167

    Abstract: Background: Alopecia areata (AA) is associated with negative impacts on the quality of life (QoL). Data on this impact are lacking for Canadian patients and their caregivers.: Objective: This study aims to investigate the burden of AA on Canadian ... ...

    Abstract Background: Alopecia areata (AA) is associated with negative impacts on the quality of life (QoL). Data on this impact are lacking for Canadian patients and their caregivers.
    Objective: This study aims to investigate the burden of AA on Canadian patients and their caregivers.
    Methods: We created 4 online surveys for patients 5-11 years old, 12-17 years old, and ≥18 years old and for caregivers of children (<18 years old) with AA. These were disseminated through the Canadian Alopecia Areata Foundation (CANAAF) website and to dermatologists across Canada.
    Results: In total, 115 adult patients (n=100, 87%, female), 14 pediatric patients (n=13, 92.9%, female), and 15 caregivers completed the surveys online. The majority (n=123, 95%) of patients felt uncomfortable or self-conscious about their appearance. Camouflaging hair loss with hats, scarves, and hairpieces was a common practice for 11 (78.6%) pediatric and 84 (73%) adult patients. Avoidance of social situations was reported by 8 (57.1%) pediatric and 75 (65.2%) adult patients. Constant worry about losing the achieved hair growth was a concern for 8 (57.1%) pediatric and 75 (65.2%) adult patients. On a scale of 1-5, the mean score of caregivers' own feelings of sadness or depression about their child's AA was 4.0 (SD 0.9) and of their feelings of guilt or helplessness was 4.2 (SD 1.2). The impact on the QoL was moderate for both children and adults. Based on the Adjustment Disorder New Module-20 (ADNM-20), 71 (61.7%) of 115 patients were at high risk of an adjustment disorder. Abnormal anxiety scores were recorded in 40 (34.8%) patients compared to abnormal depression scores in 20 (17.4%) patients.
    Conclusions: This study confirmed a significant burden of AA on Canadian patients' and caregivers' QoL.
    Language English
    Publishing date 2022-10-06
    Publishing country Canada
    Document type Journal Article
    ISSN 2562-0959
    ISSN (online) 2562-0959
    DOI 10.2196/39167
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Psychosocial impact of epidermolysis bullosa on patients: A qualitative study.

    Sangha, Nimrita / MacLellan, A Nikolas / Pope, Elena

    Pediatric dermatology

    2021  Volume 38, Issue 4, Page(s) 819–824

    Abstract: Background: Epidermolysis bullosa (EB) is an inherited disorder that results in painful skin blisters requiring daily wound care. The psychosocial impact of EB is one of the most significant concerns for patients, but there is minimal research ... ...

    Abstract Background: Epidermolysis bullosa (EB) is an inherited disorder that results in painful skin blisters requiring daily wound care. The psychosocial impact of EB is one of the most significant concerns for patients, but there is minimal research addressing these concerns or ways to improve patient quality of life (QoL).
    Objective: To examine the psychosocial impact of EB on affected patients and ways to improve their QoL.
    Methods: Eight EB participants were selected from the 2006 DEBRA Family Conference Day in Toronto. Participants were interviewed by a social worker and a field evaluator. The transcript of each interview was assessed using qualitative content analysis.
    Results: Four themes were identified: school interaction, daily life, family interactions, and societal interactions. Participants reported being teased and avoided by peers, and they felt their conditions were misunderstood by the general public. School absenteeism resulted in some patients falling behind in school, which may have been misinterpreted as intellectual impairment. Patients acknowledged significant dependence on others and felt they were contributing to caregiver burden.
    Conclusions: Our findings highlight the psychosocial impact of EB on patients. As EB awareness and resources to support patients and caregivers have improved since this study was conducted, more studies exploring the current landscape and opportunities to improve quality of life are needed.
    MeSH term(s) Caregivers ; Epidermolysis Bullosa ; Humans ; Pain ; Qualitative Research ; Quality of Life
    Language English
    Publishing date 2021-06-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605539-4
    ISSN 1525-1470 ; 0736-8046
    ISSN (online) 1525-1470
    ISSN 0736-8046
    DOI 10.1111/pde.14656
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Systematic Review of Health-Related Quality of Life Impact in Juvenile Localized Scleroderma.

    Sanchez-Espino, Luis F / Luca, Nadia / Pope, Elena / Laxer, Ronald M / Knight, Andrea M / Sibbald, Cathryn

    Arthritis care & research

    2024  Volume 76, Issue 3, Page(s) 340–349

    Abstract: Objective: The prevalence and types of psychosocial complications of juvenile localized scleroderma (JLS), also known as morphea, an inflammatory and sclerosing disease involving the skin, fascia, muscle, and bone, are poorly understood.: Methods: We ...

    Abstract Objective: The prevalence and types of psychosocial complications of juvenile localized scleroderma (JLS), also known as morphea, an inflammatory and sclerosing disease involving the skin, fascia, muscle, and bone, are poorly understood.
    Methods: We performed a systematic review of literature published between 2000 and 2020 in PubMed, EMBASE, the Cochrane Skin Group Specialized Register, the Cochrane Central Register of Controlled Trials, and the Cumulative Index to Nursing and Allied Health Literature using the search terms "scleroderma, localized," "Morphea," "anxiety," "depression," "resilience," "social stigma," "quality of life," "mood," or "stress" and limited the search to pediatric patients and English language. Patient demographics, characteristics of JLS, and comorbidities were extracted. The outcomes included measures of health-related quality of life (HRQoL), psychosocial functioning, evaluation of self-perception, and the treatment burden of the study population. The protocol was registered with PROSPERO (CRD42021257124). Thematic synthesis generated descriptive analysis.
    Results: Thirteen studies fulfilled the inclusion criteria: three retrospective cohort studies, two prospective cohort studies, and eight cross-sectional studies. A total of 690 pediatric patients with JLS were included (n = 484 with linear scleroderma). Six studies used the Children's Dermatology Life Quality Index, reporting little to no effect on HRQoL. One study used the Health-Related Quality of Life in Children and Adolescents Questionnaire and did not find differences between children with JLS or atopic dermatitis and healthy controls. One study used a self-perception questionnaire that showed normal self-worth of patients with JLS. Two studies used focus groups, both reporting elevated levels of stress, decreased self-worth, "feeling different," and bullying/teasing in patients with JLS. These emotions were associated with skin symptoms (pain, itch, and tightness), physical limitations, and treatment burden.
    Conclusion: Overall, quantitative studies did not report a statistically significant impairment in HRQoL in JLS. However, qualitative studies (focus groups) reported significant psychosocial impacts related to JLS. There is a need to develop a JLS-specific tool for the HRQoL evaluation of this population.
    MeSH term(s) Adolescent ; Humans ; Child ; Quality of Life ; Scleroderma, Localized/diagnosis ; Retrospective Studies ; Cross-Sectional Studies ; Prospective Studies
    Language English
    Publishing date 2024-01-07
    Publishing country United States
    Document type Systematic Review ; Journal Article
    ZDB-ID 645059-3
    ISSN 2151-4658 ; 0893-7524 ; 2151-464X
    ISSN (online) 2151-4658
    ISSN 0893-7524 ; 2151-464X
    DOI 10.1002/acr.25243
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: A 3-week-old infant with a unilateral facial mass.

    Mikhail, Mirriam / Pope, Elena / Friedman, Jeremy N

    Paediatrics & child health

    2021  Volume 26, Issue 8, Page(s) 448–450

    Language English
    Publishing date 2021-04-07
    Publishing country England
    Document type Case Reports
    ZDB-ID 2106767-3
    ISSN 1918-1485 ; 1205-7088
    ISSN (online) 1918-1485
    ISSN 1205-7088
    DOI 10.1093/pch/pxab010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top